Evaluation of99mTc labeled diadenosine tetraphosphate as an atherosclerotic plaque imaging agent in experimental models

Cao Wei , Zhang Yongxue , An Rui

Current Medical Science ›› 2006, Vol. 26 ›› Issue (5) : 278 -280.

PDF
Current Medical Science ›› 2006, Vol. 26 ›› Issue (5) : 278 -280. DOI: 10.1007/BF02829550
Article

Evaluation of99mTc labeled diadenosine tetraphosphate as an atherosclerotic plaque imaging agent in experimental models

Author information +
History +
PDF

Abstract

The potential of99mTc labeled P1, P4-di (adenosine-5’)-tetraphosphate (Ap4A) for imaging experimental atherosclerotic plaques was evaluated in New Zealand white (NZW) rabbits. To label the99mTc to Ap4A, stannous tartrate solution was used.99mTc-Ap4A was purified on a Sephadex G-25 column. The radiochemistry purities of99mTc-Ap4A were 85% to 91%. Biodistribution study revealed99mTc-Ap4A cleared from blood rapidly. Thirty min after99mTc-Ap4A administrated on NZW atherosclerotic rabbits, lesion to blood (target/blood, T/B) ratio was 3.17±1.27, and lesions to normal (target/non-target, T/NT) ratio was 5.23±1.87. Shadows of atherosclerotic plaques were clearly visible on radioautographic film. Aortas with atherosclerotic plaques also could be seen on ex vivo gamma camera images. Atherosclerotic abdominal aortas were clearly visible on in vivo images 15 min to 3 h after99mTc-Ap4A administration.99mTc-labeled Ap4A can be used for rapid noninvasive detection of experimental atherosclerotic plaque.

Keywords

technetium / diadenosine tetraphosphate / atherosclerotic plaque / radionuclide imaging

Cite this article

Download citation ▾
Cao Wei, Zhang Yongxue, An Rui. Evaluation of99mTc labeled diadenosine tetraphosphate as an atherosclerotic plaque imaging agent in experimental models. Current Medical Science, 2006, 26(5): 278-280 DOI:10.1007/BF02829550

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

GuoY. The Animal Models of Human Disease (Chinese), 1982, Beijing, Peolples Health Publication: 129-134

[2]

GrundyS M. Atherosclerosis imaging and the future of lipid management. Circulation, 2004, 110(23): 3509-3511

[3]

RapaportE, ZamecnikP C. Presence of diadenosine 5’, 5"-P1, P4-tetraphosphate (Ap4A) in mammalian cells in levels varying widely with proliferative activity of the tissue: a possible positive “pleiotypic activator”. Proc Natl Acad Sci USA, 1976, 73(11): 3984-3988

[4]

NarulaJ, VirmaniR, IskandrianA E. Strategic targeting of atherosclerotic lesions. J Nucl Cardiol, 1999, 6: 81-90

[5]

PintorJ, Miras-PortugalM T. Diadenosine polyphosphates (APXA) as new neurotransmitters. Drug Dev Res, 1993, 28: 259-262

[6]

ElmalehD R, NarulaJ, BabichJ W, et al.. Rapid noninvasive detection of experimental atherosclerotic lesions with novel99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci U S A, 1998, 95: 691-695

[7]

ZhangY X, WuZ J, CaoW. Radioiodine labeled SP-4 as an imaging agent for atherosclerotic plaques. Nucl Sci Tech, 2000, 11(4): 234-239

AI Summary AI Mindmap
PDF

97

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/